Introduction
The nervous system and analgesia therapeutic area represents one of the longest treatment cycles in pharmacotherapy: in China alone, over 40 million patients suffer from diabetic peripheral neuropathy, and over 3 million live with Parkinson's disease. Migraine, insomnia, epilepsy, schizophrenia, depression, and anxiety also require long-term, regular medication. Mirogabalin (a calcium channel α2δ ligand), Pramipexole (a dopamine receptor agonist), and Flurbiprofen (an NSAID analgesic/anti-inflammatory) are key products within this category. Drug substances containing primary or secondary amine structures face additional regulatory scrutiny due to the risk of N-nitroso drug substance-related impurities (NDSRI). Given that these medications are typically taken for years, drugs, impurities, and metabolites can accumulate in the body over time, making impurity control a matter of serious concern.
As a professional impurity reference standard supplier deeply rooted in this field, Sinco focuses in this issue on impurity projects related to three major nervous system and analgesia drugs — Mirogabalin, Pramipexole, and Flurbiprofen — as well as N-nitroso (N-Nitroso) impurities. We provide a full set of compliant analytical spectra to offer traceable reference support for your impurity research.
Star Products of This Issue
Calcium Channel α2δ Ligand: Mirogabalin Impurities
[Common Challenges] The bicyclo[3.2.0]heptane skeleton features highly reactive synthetic intermediates with difficult selectivity control; multiple chiral centers make stereoisomer separation challenging. The molecule contains a primary amine fragment, posing a risk of N-nitrosamine (NDSRI) impurity formation. It is also sensitive to heat and moisture, resulting in numerous degradation products.
[Sinco Provides] Over 120+ related impurity structures covered to date. Full sets of compliant spectra are available to support NDSRI reference standard research and analytical method development.
Dopamine Receptor Agonist: Pramipexole Impurities
[Common Challenges] The 4,5,6,7-tetrahydrobenzo[d]thiazole core undergoes multi-step amination and condensation, leading to a complex process impurity profile. The side-chain secondary amine is prone to NDSRI formation. With a single chiral center, strict control of the (S)-configuration is required.
[Sinco Provides] Over 60+ related impurity structures covered. Full structural elucidation spectra (including COA, NMR, MS, HPLC, etc.) are available to support chiral method development, transfer, and system suitability verification.
NSAID Analgesic/Anti-inflammatory: Flurbiprofen Impurities
[Common Challenges] The biphenylpropionic acid skeleton contains a single chiral center, requiring high-resolution separation and quantification of R/S enantiomers. The carboxylic acid structure is prone to esterification and degradation, and the impurity profile varies with dosage form. Ophthalmic drops are low-dose formulations where impurity limits are in the ppm range, making quantification particularly difficult.
[Sinco Provides] Over 100+ related impurity structures covered. Full authoritative spectra are available to provide compliant reference standard support for chiral method development, impurity quantification, and impurity profile consistency evaluation.
N-Nitroso Impurities
[Common Challenges] Brexpiprazole (antipsychotic), Daridorexant (insomnia), Rimegepant (migraine), and Prilocaine (local anesthesia) all contain amine structures and carry a risk of NDSRI generation under certain conditions. NDSRI reference standards are structurally diverse and scarce in supply, often causing method development to stall due to the lack of a reference standard.
[Sinco Provides] Over 700+ related impurity structures covered. Full analytical spectra are available to support trace-level method development.
Why Choose Sinco?
✅ Compliance Foundation: CQC certification + full structural elucidation spectra, ensuring a complete data chain.
✅ Independent Synthesis: 30,000+ self-developed library; capable of synthesizing high-difficulty custom impurities.
✅ Efficient Delivery: 24-hour response; in-stock items delivered within 2–4 business days; trusted by customers in 40 countries worldwide.
For more impurity-related information, please visit:
Sinco — Striving to Make Pharmaceutical R&D More Reassuring
https://www.sincopharmachem.net/